Search Results

The SBi SR MTP Toe Implant is intended for use as a hemi-arthroplasty implant for the metatarsophalangeal joint, for the treatment of degenerative and posttraumatic arthritis, hallux valgus, hallux rigidus, and an unstable or painful metatarsophalangeal (MTP) joint. The SBi SR MTP Toe Implant is intended for implantation with and without bone cement.

The SBi SR MTP Toe Implant is a one-piece, stemmed device intended to replace the articulating surface of the metatarsal at the MTP joint. The implant is available in a range of sizes to match the geometry of the metatarsal head. Design features include an articulating surface which extends posteriorly on the superior side of the implant and a gently barbed stem to improve fixation in the metatarsal. The implants are made from wrought CoCrMo alloy (ASTM F1587) with a plasma coating comprised of commercially pure titanium (ASTM F1580).

This device is a SBi SR MTP Toe Implant, a medical device, not an AI/ML device. Therefore, the concepts of "acceptance criteria" and "study that proves the device meets the acceptance criteria" in the context of AI/ML performance metrics (such as sensitivity, specificity, F1-score, sample sizes for test/training sets, expert consensus for ground truth, MRMC studies) are not applicable.

Instead, for a medical device like this implant, the "acceptance criteria" and "proof" involve demonstrating substantial equivalence to a predicate device already legally marketed. This typically involves comparing characteristics such as:

• Intended Use: The purpose for which the device is used.
• Technological Characteristics: The materials, design, and other technical aspects of the device.
• Performance Data: This might include mechanical testing (e.g., strength, wear) to show the new device performs similarly or better than the predicate, or sometimes clinical data if there are significant differences in technological characteristics or intended use that raise new safety or effectiveness questions.

The provided document, a 510(k) summary and FDA clearance letter, explicitly states how this "acceptance" was met:

Substantial Equivalence:

• The document states: "Documentation was provided which demonstrated the SBi SR MTP Toe Implant is substantially equivalent to other legally marketed devices."
• The FDA's letter confirms: "We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified..."

Therefore, the "study" proving the device met "acceptance criteria" was a demonstration of substantial equivalence based on a comparison to a predicate device, as required for 510(k) clearance by the FDA. The document does not contain the specific performance data (e.g., mechanical testing results) that would have been submitted to demonstrate this equivalence, but rather the conclusion of the FDA's review.

Given this context, I cannot fill in the table or answer the subsequent questions as they pertain to AI/ML device evaluations, which are not relevant here.

Ask a specific question about this device